Compass Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$668K Sell
1,845
-500
-21% -$171K 0.04% 64
2026
Q1
$825K Hold
2,345
0.05% 57
2025
Q4
$768K Hold
2,345
0.04% 61
2025
Q3
$662K Hold
2,345
0.04% 62
2025
Q2
$655K Buy
+2,345
New +$664K 0.04% 55

Other funds holding AMGN

Compass Capital Management's AMGN Position: Q2 2026 in Review

Compass Capital Management reduced its Amgen (AMGN) stake by 21% in Q2 2026, selling an estimated $171K and leaving 1,845 shares worth $668K. The position accounts for 0.04% of the portfolio, ranked #64.

Compass Capital Management first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $825K in Q1 2026. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Compass Capital Management held 1,845 shares of Amgen worth $668K as of Q2 2026.
  • Compass Capital Management sold 500 Amgen shares in Q2 2026, an estimated $171K.
  • Amgen made up 0.04% of Compass Capital Management's portfolio in Q2 2026, its #64 holding.
  • Compass Capital Management first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • Compass Capital Management's Amgen position peaked at $825K in Q1 2026.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Compass Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.